Abstract
Purpose
The risk factors for secondary stomach carcinogenesis after distal gastrectomy have not been evaluated in detail.
Methods
Using gastrointestinal endoscopy, we examined 112 patients who had undergone gastrectomy. Biopsy specimens were taken from the stoma and the upper corpus mucosa in the remnant stomach to examine the associations among Helicobacter pylori (H.pylori) infection, bile reflux, and the expressions of interleukin-8 (IL-8), cyclo-oxygenase-2 (COX-2), and trefoil factor family 1 (TFF1) genes in the stomach mucosa.
Results
The IL-8 levels in the corpus mucosa were significantly higher in the H.pylori-positive patients than in the H.pylori-negative patients (P = 0.015). The IL-8 levels were significantly higher in the stomal mucosa than in the corpus mucosa in the H.pylori-positive patients (P = 0.047). The COX-2 levels in the corpus mucosa tended to be higher in the H.pylori-positive patients, but these levels were not significantly different in the stoma mucosa. The COX-2 levels in the corpus were significantly higher after Billroth II (BII) anastomosis than after Billroth I (BI) anastomosis (P = 0.041). TFF1 expression in the stoma was higher in the H.pylori-positive patients than in the H.pylori-negative patients, but the difference was not significant.
Conclusions
Both H.pylori infection and bile reflux increased IL-8 levels after BI anastomosis. Furthermore, COX-2 levels were higher after BII than after BI anastomosis. These indicators will become useful not only as biomarkers to predict the degree of inflammation in the stomach mucosa, but also as surrogate biomarkers to predict the risk of secondary stomach carcinogenesis in the remnant stomach mucosa.
Similar content being viewed by others
References
P Hohenberger S Gretschel (2003) ArticleTitleGastric cancer Lancet 362 305–15 Occurrence Handle10.1016/S0140-6736(03)13975-X Occurrence Handle12892963
Bernard W, Steward PK. GLOBOCANI. Stomach cancer. Lyon, France: IARC/WHO, IARC Press; 2003
JR Kelley JM Duggan (2003) ArticleTitleGastric cancer epidemiology and risk factors J Clin Epidemiol 56 1–9 Occurrence Handle10.1016/S0895-4356(02)00534-6 Occurrence Handle12589864
N Uemura S Okamoto S Yamamoto N Matsumura S Yamaguchi M Yamakido et al. (2001) ArticleTitleHelicobacter pylori infection and the Development of Gastric Cancer N Engl J Med 345 829–32 Occurrence Handle10.1056/NEJMoa001999
T Matsuhisa N Yamada S Kato N Matsukura (2003) ArticleTitleHelicobacter pylori infection, mucosal atrophy and intestinal metaplasia in Asian populations: a comparative study in age-, gender- and endoscopic diagnosis-matched subjects Helicobacter 8 29–35 Occurrence Handle10.1046/j.1523-5378.2003.00121.x Occurrence Handle12603614
N Lunet H Barros (2003) ArticleTitleHelicobacter pylori infection and gastric cancer: facing the enigmas Int J Cancer 106 953–60 Occurrence Handle10.1002/ijc.11306 Occurrence Handle12918076 Occurrence Handle1:CAS:528:DC%2BD3sXnsVGrsbc%3D
PC Konturek SJ Konturek P Pierzchalski W Bielanski A Duda K Marlicz et al. (2001) ArticleTitleCancerogenesis in Helicobacter pylori infected stomach — role of growth factors, apoptosis and cyclooxygenases Med Sci Monit 7 1092–107 Occurrence Handle11535962 Occurrence Handle1:CAS:528:DC%2BD3MXnsFWmur8%3D
Y Yamaoka M Kita T Kodama N Sawai T Tanahashi K Kashima et al. (1998) ArticleTitleChemokines in the gastric mucosa in Helicobacter pylori infection Gut 42 609–17 Occurrence Handle9659152 Occurrence Handle1:STN:280:DyaK1czitlarug%3D%3D Occurrence Handle10.1136/gut.42.5.609
T Shimada A Terano (1998) ArticleTitleChemokine expression in Helicobacter pylori-infected gastric mucosa J Gastroenterol 33 613–7 Occurrence Handle9773923 Occurrence Handle1:CAS:528:DyaK1cXms1SltLk%3D
M Leivonen S Nordling C Haglund (1997) ArticleTitleDoes Helicobacter pylori in the gastric stump increase the cancer risk after certain reconstruction types? Aliment Pharmacol Ther Anticancer Res 17 IssueID5B 3893–6 Occurrence Handle1:STN:280:DyaK1c%2FovFagtA%3D%3D
KA Johannesson E Hammar C Stael von Holstein (2003) ArticleTitleMucosal changes in the gastric remnant: long-term effects of bile reflux diversion and Helicobacter pylori infection Eur J Gastroenterol Hepatol 15 35–40 Occurrence Handle12544692
P Sharma N Vakil (2003) ArticleTitleHelicobacter pylori and reflux disease Aliment Pharmacol Ther 17 297–305 Occurrence Handle10.1046/j.1365-2036.2003.01428.x Occurrence Handle12562442 Occurrence Handle1:STN:280:DC%2BD3s%2Flt1ykuw%3D%3D
P Tomtitchong M Onda N Matsukura A Tokunaga S Kato T Matsuhisa et al. (1998) ArticleTitleHelicobacter pylori infection in the remnant stomach after gastrectomy: with special reference to the difference between Billroth I and II anastomoses J Clin Gastroenterol 27 IssueIDSuppl 1 S154–8 Occurrence Handle9872514
T Katsube K Ogawa K Hamaguchi M Murayama S Konno T Shimakawa et al. (2002) ArticleTitlePrevalence of Helicobacter pylori in the residual stomach after gastrectomy for gastric cancer Hepatogastroenterology 49 128–32 Occurrence Handle11941936
N Matsukura T Tajiri S Kato A Togashi G Masuda I Fujita et al. (2003) ArticleTitleHelicobacter pylori eradication therapy for the remnant stomach after gasterctomy Gastric Cancer 6 100–7 Occurrence Handle12861401
JE Crabtree IJ Lindley (1994) ArticleTitleMucosal interleukin-8 and Helicobacter pylori-associated gastroduodenal disease Eur J Gastroenterol Hepatol 6 IssueIDSuppl 1 S33–8 Occurrence Handle7735932
JE Crabtree Z Xiang IJ Lindley DS Tompkins R Rappuoli A Covacci (1995) ArticleTitleInduction of interleukin-8 secretion from gastric epithelial cells by a cagA negative isogenic mutant of Helicobacter pylori J Clin Pathol 48 967–9 Occurrence Handle8537502 Occurrence Handle1:STN:280:DyaK287jvVWluw%3D%3D
Y Konda H Nishisaki O Nakano K Matsuda K Wada M Nagao et al. (1990) ArticleTitleProstaglandin protects isolated guinea pig chief cells against ethanol injury via an increase in diacylglycerol J Clin Invest 86 1897–903 Occurrence Handle2174910 Occurrence Handle1:CAS:528:DyaK3MXhsl2qtA%3D%3D Occurrence Handle10.1172/JCI114922
F Halter A Schmassmanm BM Peskar AS Tarnawski (2001) ArticleTitleCyclooxygenase 2-implication on maintenance of gastric mucosal integrity and ulcer healing: controversial issues and perspectives Gut 49 443–53 Occurrence Handle10.1136/gut.49.3.443 Occurrence Handle11511570 Occurrence Handle1:CAS:528:DC%2BD3MXnt1Cqu78%3D
A Tatsuguchi C Sakamoto K Wada T Akamatsu T Tsukui K Miyake et al. (2000) ArticleTitleLocalisation of cyclooxygenase 1 and cyclooxygenase 2 in Helicobacter pylori relate gastritis and gastric ulcer tissues in humans Gut 46 782–9 Occurrence Handle10.1136/gut.46.6.782 Occurrence Handle10807888 Occurrence Handle1:CAS:528:DC%2BD3cXltFOiur4%3D
BP van Rees K Saukkonen A Ristimaki W Polkowski GN Tytgat P Drillenburg et al. (2002) ArticleTitleCyclooxygenase-2 expression during carcinogenesis in the human stomach J Pathol 196 171–9 Occurrence Handle10.1002/path.1033 Occurrence Handle11793368 Occurrence Handle1:CAS:528:DC%2BD38XhsVOgu7Y%3D
SK Boolbol AJ Dannenberg A Chadburn C Martucci XJ Guo JT Ramonetti et al. (1996) ArticleTitleCyclooxygenase-2 overexpression and tumor formation are blocked by sulindac in a murine model of familial adenomatous polyposis Cancer Res 56 2556–60 Occurrence Handle8653697 Occurrence Handle1:CAS:528:DyaK28XjtlCgtbc%3D
R Poulsom NA Wright (1993) ArticleTitleTrefoil peptides: a newly recognized family of epithelial mucin-associated molecules Am J Physiol 265 205–13
R Carvalho T Kayademir P Soares P Canedo S Sousa C Oliveira et al. (2002) ArticleTitleLoss of heterozygosity and promoter methylation, but not mutation, may underlie loss of TFF1 in gastric carcinoma Lab Invest 82 1319–26 Occurrence Handle12379766 Occurrence Handle1:CAS:528:DC%2BD38Xns1Cmu7c%3D
DP Calnan BR Westley FE May DN Floyd T Marchbank RJ Playford (1999) ArticleTitleThe trefoil peptide TFF1 inhibits the growth of the human gastric adenocarcinoma cell line AGS J Pathol 188 312–7 Occurrence Handle10.1002/(SICI)1096-9896(199907)188:3<312::AID-PATH360>3.0.CO;2-P Occurrence Handle10419601 Occurrence Handle1:CAS:528:DyaK1MXltVKruro%3D
O Lefebvre MP Chenard R Masson J Linares A Dierich M LeMeur et al. (1996) ArticleTitleGastric mucosa abnormalities and tumorigenesis in mice lacking the pS2 trefoil protein Science 274 259–62 Occurrence Handle10.1126/science.274.5285.259 Occurrence Handle8824193 Occurrence Handle1:CAS:528:DyaK28XmtlWltrY%3D
S Kato N Matsukura A Togashi G Masuda N Matsuda N Yamada et al. (2004) ArticleTitleSex differences in mucosal response to Helicobacter pylori infection in the stomach and variations in interleukin-8, COX-2 and trefoil factor family 1 gene expression Aliment Pharmacol Ther 20 17–24 Occurrence Handle15298601 Occurrence Handle1:CAS:528:DC%2BD2cXnvVyjt70%3D
J Pan Q Xiang S Ball (2000) ArticleTitleUse of a novel real-time quantitative reverse transcription-polymerase chain reaction method to study the effects of cytokines on cytochrome P450 mRNA expression in mouse liver Drug Metab Dispos 28 709–13 Occurrence Handle10820145 Occurrence Handle1:CAS:528:DC%2BD3cXjvFeltrc%3D
WP Bowen JE Carey A Miah HF McMurray PW Munday RS James et al. (2000) ArticleTitleMeasurement of cytochrome P450 gene induction in human hepatocytes using quantitative real-time reverse transcriptase-polymerase chain reaction Drug Metab Dispos 28 781–8 Occurrence Handle10859152 Occurrence Handle1:CAS:528:DC%2BD3cXks12isL8%3D
JE Crabtree P Peichl JI Wyatt U Stachl IJ Lindley (1993) ArticleTitleGastric interleukin-8 and IgA IL-8 autoantibodies in Helicobacter pylori infection Scand J Immunol 37 65–70 Occurrence Handle8418474 Occurrence Handle1:CAS:528:DyaK3sXhsVGrtL8%3D
JE Crabtree JI Wyatt LK Trejdosiewicz P Peichl PH Nichols N Ramsay et al. (1994) ArticleTitleInterleukin-8 expression in Helicobacter pylori infected, normal, and neoplastic gastroduodenal mucosa J Clin Pathol 47 61–6 Occurrence Handle8132812 Occurrence Handle1:STN:280:DyaK2c7nvFGgsw%3D%3D
AJ Dannenberg NK Altorki JO Boyle C Dang LR Howe BB Weksler et al. (2001) ArticleTitleCyclo-oxygenase 2: a pharmacological target for the prevention of cancer Lancet Oncol 2 544–51 Occurrence Handle10.1016/S1470-2045(01)00488-0 Occurrence Handle11905709 Occurrence Handle1:CAS:528:DC%2BD3MXntFCnu7o%3D
RA Gupta RN Dubois (2001) ArticleTitleColorectal cancer prevention and treatment by inhibition of cylooxygenase-2 Nat Rev Cancer 1 11–21 Occurrence Handle10.1038/35094017 Occurrence Handle11900248 Occurrence Handle1:STN:280:DC%2BD387mvVOhsA%3D%3D
K Saukkonen J Rintahaka A Sivula CJ Buskens BP Van Rees MC Rio et al. (2003) ArticleTitleCyclooxygenase-2 and gastric carcinogenesis APMIS 111 915–25 Occurrence Handle10.1034/j.1600-0463.2003.1111001.x Occurrence Handle14616542 Occurrence Handle1:CAS:528:DC%2BD3sXps12lsbw%3D
Ristimäki A. Van Rees (2001) ArticleTitleCyclooxygenase-2 in carcinogenesis of the gastrointestinal tract Scand J Gastroenterol 36 897–903 Occurrence Handle11521977 Occurrence Handle1:CAS:528:DC%2BD3MXmslWgtbY%3D
K Saukkonen C Tomasetto K Narko MC Rio A Ristimaki (2003) ArticleTitleCyclooxygenase-2 expression and effect of celecoxib in gastric adenomas of trefoil factor 1-deficient mice Cancer Res 63 3032–6 Occurrence Handle12810622 Occurrence Handle1:CAS:528:DC%2BD3sXks1eit7c%3D
S Mohammed DW Croom (1999) ArticleTitleGastropathy due to celecoxib, a cyclooxygenase-2 inhibitor N Engl J Med 340 2005–6 Occurrence Handle10.1056/NEJM199906243402516 Occurrence Handle10383283 Occurrence Handle1:STN:280:DyaK1M3os1Sjug%3D%3D
BF Mandell (1999) ArticleTitleCOX 2-selective NSAIDs: biology, promises, and concerns Cleve Clin J Med 66 285–92 Occurrence Handle10330781 Occurrence Handle1:STN:280:DyaK1M3mtFSnsg%3D%3D
Y Lee A Tokunaga T Tajiri G Masuda T Okuda I Fujita et al. (2004) ArticleTitleInflammation of the gastric remnant after gastrectomy: mucosal erythema is associated with bile reflux and inflammatory cellular infiltration is associated with Helicobacter pylori infection J Gastroenterol 39 520–6 Occurrence Handle15235868
N Matsukura M Onda (2000) ArticleTitleGastric remnant-stump cancer and Helicobacter pylori (in Japanese) Gastroenterol Surg 23 1133–8
T Terada R Sakagami Y Tabuchi M Maeda (2001) ArticleTitleCharacterization of the mouse TFF1 (pS2) gene promoter region Biol Pharm Bull 24 135–9 Occurrence Handle10.1248/bpb.24.135 Occurrence Handle11217079 Occurrence Handle1:CAS:528:DC%2BD3MXhtVSitbo%3D
JL Newton A Allen BR Westley FE May (2000) ArticleTitleThe human trefoil peptide, TFF1, is present in different molecular forms that are intimately associated with mucus in normal stomach Gut 46 312–20 Occurrence Handle10.1136/gut.46.3.312 Occurrence Handle10673290 Occurrence Handle1:CAS:528:DC%2BD3cXhvFeks7w%3D
T Saitoh T Mochizuki T Suda Y Aoyagi Y Tsukada R Narisawa et al. (2000) ArticleTitleElevation of TFF1 gene expression during healing of gastric ulcer at non-ulcerated sites in the stomach: semiquantification using the single tube method of polymerase chain reaction J Gastroenterol Hepatol 15 604–9 Occurrence Handle10.1046/j.1440-1746.2000.02209.x Occurrence Handle10921412 Occurrence Handle1:CAS:528:DC%2BD3cXltFOjtrk%3D
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Xing, C., Kato, S., Matsukura, N. et al. Interleukin-8, Cyclo-oxygenase-2, and Trefoil Factor Family 1 Gene Expression and Their Association with Helicobacter pylori Infection in the Remnant Stomach. Surg Today 35, 1026–1032 (2005). https://doi.org/10.1007/s00595-005-3075-7
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s00595-005-3075-7